• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccines / HPV / HPV Vaccination Part Two: Immunization Programmes

HPV Vaccination Part Two: Immunization Programmes

July 18, 2012 By admin Leave a Comment

By Ellen Bown, Contributing Author from the UK

HPV Vaccination Programs

The research leading to HPV vaccine development began in the 1980’s. Currently there are two vaccines on the market worldwide; Gardasil manufactured by Merck Inc. and Cervarix manufactured by GlaxoSmithKline. In September 2008 the government began a mass immunisation programme aimed at all girls in the UK between the ages of 12 – 13, with a catch up programme for girls 14 – 17 years.  At the time their vaccination of choice was Cervarix (The government is changing to Gardasil in September 2012). Cervarix is a vaccine which is supposed to prevent early stage cervical cancers i.e. Pre-cancerous lesions and thus prevent cervical cancer caused by the HPV types 16 and 18.  However, at the time of the immunization programme being rolled out this vaccine had never been tested on children younger than 15 years. Professor Martina Doren, of the Charitie Hospital in Berlin criticises this fact along with 12 other distinguished professors.1

I have been unable to find any documents stating that tests have now been carried out on this age group. As previously mentioned, protocols are in place to make sure vaccines are safe before being used, but the first question to ask would be; How do we know they are safe to use on this age group when the tests have never been carried out in full?

Furthermore it has been shown by both Merck Inc. and GlaxoSmithKline that if you are already infected by strains 16 and or 18 then the vaccine will not provide you with any protection.  If you keep getting infected then the risk of it developing into pre-cancerous lesions may increase by 44.6% after Gardasil and 32.5% after Cervarix. So we may find in a few years, as with smallpox, most cases of cervical cancer are actually caused by the vaccination itself rather than the naturally occurring infection. An infection, let’s remember that in most cases clears itself anyway. Do we want to take that risk?

Toxins:

The ingredients in Cervarix are;  active HPV-16 L1 protein and HPV-18 L1 protein, 3-Odesacyl-4’ monophosphoryl lipid A (MPL), aluminium hydroxide, sodium chloride and sodium phosphate-monobasic.

  • 3-Odesacyl-4’ monophosphoryl lipid A (MPL) is the adjuvant which is designed to stimulate the body’s immune system. MPL is a derivative of lipid A from Salmonella Minnesota R595. Salmonella is a bacterial infection which lives in the intestinal tract of animals, which is then transmitted to humans by eating foods contaminated by animal faeces causing illness and death.
  • Aluminium hydroxide is a protoplasmic poison and a deadly, persistent neurotoxin. “Since 1934, Aluminum Hydroxide has been used as an adjuvant to boost the immune response from vaccines. The effects of poisons can be quick or extremely slow – building gradually up creating low grade debilitation diseases like in chronic fatigue syndrome or devastating neurological disorders like MS, ALS, and Alzheimer’s disease. Though neurodegenerative disorders have several pathways in their creation but nothing will burn up a neuron faster than mercury. This is also the case for aluminum hydroxide, just to a lesser extent. Vancouver neuroscientist Dr. Chris Shaw just finished his research that shows a link between the aluminum hydroxide used in vaccines, and symptoms associated with Parkinson’s, amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease), and Alzheimer’s. Autopsy reports on Alzheimer’s patients found 70% more aluminum in the brain.” 2 

These are just two of the vaccines ingredients. In 1999 the FDA recommended removing mercury (Thimerosal) from all products, including vaccines and yet aluminium quite clearly has similar effects and is still used.

Would you give your child poison?

References:

  1. Express.co.uk Sunday May 31st 2009
  2. IMVA International Medical Veritas Association, http://imva.info/index.php/vaccines/aluminum-hydroxide/

 

Related

Filed Under: HPV, Vaccine Marketing, Vaccine Science Tagged With: HPV VACCINES, immunization programs

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

We had no informed consent before Gardasil changed our lives.

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

forcing flu shots

Forcing Flu Shots on Health Care Workers: Who is Next?

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...